Peripheral Artery Disease Management
Peripheral Artery Disease Management is a research topic within Surgery. Science Explorer counts 42k research works in it since 1950. 13.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, treatment, and epidemiology of peripheral arterial disease (PAD), covering topics such as guidelines for diagnosis and treatment, comparison of revascularization methods, risk factors, and the impact of PAD on patients with diabetes. It also includes discussions on the use of ankle-brachial index, stents, and the prevalence of atherosclerosis-related conditions.
- Peripheral Arterial Disease
- Guidelines
- Angioplasty
- Atherosclerosis
- Claudication
- Revascularization
- Risk Factors
- Ankle-Brachial Index
- Stents
- Diabetes
- Research works
- 42k fractional, since 1950
- In the world top 10%
- 5.7k per year above
- Top-10% rate
- 13.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Peripheral Artery Disease Management research?
By volume, the United States and China publish the most (2.4k and 719 works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.4k works
- 2 China 719 works
- 3 Japan 487 works
- 4 United Kingdom 393 works
- 5 Germany 334 works
- 6 Italy 263 works
- 7 India 241 works
- 8 France 207 works
- 9 Russia 168 works
- 10 South Korea 168 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Peripheral Artery Disease Management research?
By volume in 2022–2025, Yale University publishes the most Peripheral Artery Disease Management research, followed by Massachusetts General Hospital and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 Yale UniversityUnited States 65 works
- 2 Massachusetts General HospitalUnited States 39 works
- 3 University of North Carolina at Chapel HillUnited States 33 works
- 4 Capital Medical UniversityChina 30 works
- 5 Harvard UniversityUnited States 29 works
- 6 Beth Israel Deaconess Medical CenterUnited States 26 works
- 7 University of California San DiegoUnited States 25 works
- 8 Icahn School of Medicine at Mount SinaiUnited States 24 works
- 9 Cleveland ClinicUnited States 22 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
Who are the leading researchers in Peripheral Artery Disease Management?
The most-cited researchers publishing on Peripheral Artery Disease Management include Graeme J. Hankey, Valentı́n Fuster and Luigi Ferrucci.
- 1 Graeme J. Hankey Australia 7.2k citations
- 2 Valentı́n Fuster United States 5.4k citations
- 3 Luigi Ferrucci United States 5.3k citations
- 4 Victor Aboyans France 4.9k citations
- 5 Harlan M. Krumholz United States 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Peripheral Artery Disease Management research done?
The largest centres of Peripheral Artery Disease Management research in 2022–2025 are Beijing (China), Boston (United States), New York (United States) and London (United Kingdom).
Largest cities, 2022–2025
- 1 Beijing China 151 works
- 2 Boston United States 134 works
- 3 New York United States 108 works
- 4 London United Kingdom 97 works
- 5 Tokyo Japan 86 works
- 6 Seoul South Korea 85 works
- 7 Shanghai China 75 works
- 8 New Haven United States 71 works
- 9 Moscow Russia 66 works
- 10 Baltimore United States 63 works
Where is the best place to study Peripheral Artery Disease Management?
Among universities, judged by research, Yale University, National and Kapodistrian University of Athens and University of Ferrara score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Yale UniversityUnited States | 60.7 | 9.0% | 8.8× | 65 | +43.9% |
| 2 | National and Kapodistrian University of AthensGreece | 55.0 | 28.9% | 2.2× | 8 | +228.6% |
| 3 | University of FerraraItaly | 54.0 | 24.2% | 6.6× | 8 | +55.1% |
| 4 | University of Nebraska at OmahaUnited States | 53.2 | 13.8% | 14.1× | 8 | +139.0% |
| 5 | Icahn School of Medicine at Mount SinaiUnited States | 52.1 | 11.0% | 6.8× | 24 | +114.8% |
| 6 | Harvard UniversityUnited States | 48.7 | 18.6% | 3.2× | 30 | -6.8% |
| 7 | University of Southern CaliforniaUnited States | 47.5 | 28.8% | 2.0× | 11 | +63.6% |
| 8 | Capital Medical UniversityChina | 46.6 | 12.3% | 7.1× | 30 | -11.2% |
| 9 | Medical University of South CarolinaUnited States | 46.6 | 8.1% | 8.4× | 14 | +130.2% |
| 10 | McMaster UniversityCanada | 45.7 | 20.1% | 2.5× | 9 | +143.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Peripheral Artery Disease Management research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Peripheral Artery Disease Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.